Lippincott ^® NursingCenter ^®

Departments

• Free

  3 QUESTIONS ON . . . Low- & Moderate-Grade Adverse Events in Cancer Trials: With Nathaniel S. O'Connell, PhD, at Wake Forest University School of Medicine

  Sarah DiGiulio

• Free

  Adding Durvalumab/Bevacizumab to TACE for Unresectable HCC

  Catlin Nalley

• Free

  An Assortment of Journal Abstracts to Enhance Oncology Care
• Free

  Biomarkers May Hold Therapeutic Potential for Multiple Cancers

  Chuck Holt

• Free

  Exploring Risk-Stratified Screening for Kidney Cancer

  Dibash Kumar Das

• Free

  Fate Took a Hand at Turning a Probing Mind to Oncology

  Valerie Neff Newitt

• Free

  FDA Updates Highlighting the Latest Cancer Treatments
• Free

  FOLFOXIRI + Bevacizumab Use in Metastatic Colorectal Cancer

  Catlin Nalley

• Free

  Mapping Cancer Genomes Enables Advanced Personalized Treatment

  Lindsey Nolen

• Free

  Next-Generation Therapies in Radiation Oncology

  Elizabeth Galamba

• Free

  Phase III Findings of Durvalumab + FLOT in Gastric/GEJ Cancer

  Catlin Nalley

• Free

  Plant-Based Diet Improves Sexual Health in Men With Prostate Cancer

  Warren Froelich

• Free

  Ponatinib Dose Reduction Reduces Risk of Adverse Events in CML

  Mark L. Fuerst

• Free

  Research Progress for Esophageal Cancer Detection

  Susan Jenks

• Free

  Shop Talk
• Free

  The Emerging Promise of Cancer Neuroscience

  Cynthia Washam

• Free

  The Growth of Deep Learning & Machine Learning in Cancer Outcomes

  Frieda Wiley

• Free

  Trading Family Medicine Practice for Lifesaving Lung Cancer Advocacy

  Valerie Neff Newitt

• Free

  UpToDate®
• Free

  View From the Other Side of the Stethoscope: Guiding Patients' Hopes

  Wendy S. Harpham